Month: February 2021

Studies

Phase 3 human clinical trial shows that metabolic activators accelerate recovery in COVID-19 patients
February 24, 2021October 28, 2025

The Swedish biotechnology company ScandiBio Therapeutics today announced results from the study. The study conducted in Turkey was published on February 20 on medRxiv, a preprint…

Read More Phase 3 human clinical trial shows that metabolic activators accelerate recovery in COVID-19 patients
Studies

Phase 2 human clinical trial shows that metabolic activators reduces liver fat in NAFLD patients
February 4, 2021October 28, 2025

ScandiBio Therapeutics announced results from the study “Combined Metabolic Activators Reduces Liver Fat in Nonalcoholic Fatty Liver Disease” were published on Cell Press Sneak Peek, a…

Read More Phase 2 human clinical trial shows that metabolic activators reduces liver fat in NAFLD patients